Talcum Powder Ovarian Cancer Attorneys Representing Victims Across U.S.
On May 19, 2020, Johnson & Johnson stated it would stop selling its talcum-based powder in the United States and Canada. In announcing the discontinuation of sales, Johnson & Johnson cited changes in consumer habits and ongoing litigation about the risks of cancer associated with its talcum-based baby powder. Goza & Honnold is pursuing talcum powder ovarian cancer cases on behalf of victims around the country, and we are available to schedule an attorney consultation regarding your potential case.
Thousands of cases are currently pending in the Talcum Powder Multidistrict Litigation (MDL) in the District of New Jersey. Last summer, Johnson & Johnson and other defendants in the MDL tried to prevent plaintiffs’ experts from testifying at future trials. The plaintiffs’ claims would not be able to move forward without expert testimony. However, after holding several days of hearings, Judge Freda L. Wolfson ruled on April 27 that all of the plaintiffs’ experts could testify. This ruling means trial scheduling can soon begin in the MDL.
Elsewhere in the country, many talcum powder cases against Johnson & Johnson have resulted in substantial verdicts for women suffering from ovarian cancer. Despite these verdicts and its halt in sales, Johnson & Johnson is still defending the safety of its product. The company says the original Johnson’s Baby Powder will remain on store shelves as long as supplies last, while no new batches will be manufactured or sent to retailers.
Our lawyers are continuing to fight for compensation for individuals and families affected by Johnson & Johnson’s dangerous product. If you or a loved one used talcum-based powder and developed ovarian cancer, contact Goza & Honnold today. We can evaluate your potential claim and help you understand your legal options, starting with a free case consultation. You can reach us by calling (913) 451-3433 or by filling out our online Contact form.